10May/13

Lilly Halts Drug Development After Failed Trial – Inside INdiana Business (press release)


Dividend.com

Lilly Halts Drug Development After Failed Trial
Inside INdiana Business (press release)
The study failed to show a statistically significant increase compared to placebo in disease-free survival in patients at high risk of relapse following rituximab-based chemotherapy. There were no new safety findings, and the safety data were
Lilly To Take $30M Charge After Relapse Cancer Drug Disappoints in TrialFox Business
Enzastaurin, Eli Lilly’s Lymphoma Drug Fails In Late-Stage TrialMedical Daily
Lilly Halts Development of Lymphoma Drug After Phase III FailureGenetic Engineering News

all 15 news articles »

09May/13

New tool for identifying powerful HIV antibodies – Science Daily – Science Daily (press release)


Medical Daily

New tool for identifying powerful HIV antibodies – Science Daily
Science Daily (press release)
May 9, 2013 — A team of NIH scientists has developed a new tool to identify broadly neutralizing antibodies (bNAbs) capable of preventing infection by the majority of HIV strains found around the globe, an advance that could help speed HIV vaccine
NIH Develops New Tool To Search For HIV Antibodies, Could Speed Vaccine Medical Daily
US researchers develop new tool in HIV vaccine fightFRANCE 24

all 3 news articles »